What is the main purpose of this 8-K filing by WellPoint, Inc.?

The primary purpose of this 8-K filing is to formally announce the execution of an Agreement and Plan of Merger between WellPoint, Inc. and AMERIGROUP Corporation. It serves as official notification to investors and the public about this significant corporate action.

What are the key risks associated with the announced merger, according to the filing?

The filing highlights several risks, including the need to obtain timely approvals from Amerigroup's stockholders and government/regulatory agencies, the possibility that closing conditions may not be met, the ability of both companies to successfully consummate the merger, and the risk that the anticipated benefits and synergies may not be fully realized or may take longer than expected.

Where can I find more detailed information about the merger agreement and its terms?

This 8-K filing directs investors to attached exhibits, specifically a Joint Press Release (Exhibit 99.1) and an Investor Presentation (Exhibit 99.2), which are expected to contain more comprehensive information. Further details will also be provided in Amerigroup's proxy statement, which will be filed with the SEC.

Does this filing include the financial terms of the merger?

No, this 8-K filing itself does not contain the specific financial terms of the merger. It announces the agreement and points to the press release and investor presentation for further details. Investors should refer to those accompanying documents and subsequent filings for financial information related to the transaction.

ELV 8-K SEC Disclosure

Summary

Elevance Health, Inc. (formerly WellPoint, Inc.) announced a significant development on July 9, 2012, by filing an 8-K to report the execution of an Agreement and Plan of Merger with AMERIGROUP Corporation. This filing signals the intent for a substantial acquisition, indicating a strategic move by WellPoint to expand its market presence and capabilities. Investors should note that this 8-K primarily serves as a notification of the merger agreement and the upcoming investor call to discuss the transaction. While the filing itself does not contain detailed financial terms of the deal, it directs stakeholders to accompanying exhibits, including a joint press release and an investor presentation, which are expected to provide more comprehensive information. The company has also included a cautionary statement regarding forward-looking statements, highlighting the inherent risks and uncertainties associated with such a large-scale merger, including regulatory approvals, potential integration challenges, and the realization of anticipated benefits.

Key Highlights

1WellPoint, Inc. (now Elevance Health) entered into an Agreement and Plan of Merger with AMERIGROUP Corporation on July 9, 2012.
2The filing (8-K) formally announces the execution of the merger agreement between the two companies.
3A joint press release and an investor presentation were issued concurrently and are attached as exhibits to this filing.
4The company plans to hold a conference call and investor presentation to discuss the merger details.
5The filing includes a standard cautionary statement regarding forward-looking statements and the risks associated with the proposed transaction.
6Key risks highlighted include obtaining necessary stockholder and regulatory approvals, consummating the merger, and realizing anticipated benefits and synergies.
7Additional details and information regarding the transaction will be made available through future SEC filings, including Amerigroup's proxy statement.

Elevance Health, Inc. 8-K Report, Corporate Update (Jul 9, 2012)

Summary

Key Highlights

Frequently Asked Questions